GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Basilea Pharmaceutica Ltd (CHIX:BSLNz) » Definitions » Total Operating Expense

Basilea Pharmaceutica (CHIX:BSLNZ) Total Operating Expense : CHF121.0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Basilea Pharmaceutica Total Operating Expense?

Basilea Pharmaceutica's Total Operating Expense for the six months ended in Jun. 2024 was CHF48.7 Mil. Basilea Pharmaceutica's Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 was CHF121.0 Mil.

Basilea Pharmaceutica Total Operating Expense Historical Data

The historical data trend for Basilea Pharmaceutica's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Basilea Pharmaceutica Total Operating Expense Chart

Basilea Pharmaceutica Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 131.18 124.99 121.04 102.35 108.93

Basilea Pharmaceutica Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51.52 50.83 36.63 72.31 48.66

Basilea Pharmaceutica Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF121.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Basilea Pharmaceutica Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Basilea Pharmaceutica's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Basilea Pharmaceutica Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Basilea Pharmaceutica Ltd (CHIX:BSLNz) » Definitions » Total Operating Expense
Comparable Companies
XSWX:IDIA XSWX:MOLN XSWX:NWRN XSWX:XLS XSWX:SANN XSWX:RLF XSWX:ADXN VRTX REGN ASX:CSL XKRX:207940 XBRU:UCB ALNY XBRU:ARGX XKRX:068270 BNTX BGNE MRNA SMMT UTHR
Traded in Other Exchanges
BPMUF:USA 0QNA:UK BSLN:Switzerland
Address
Hegenheimermattweg 167b, Allschwil, CHE, 4123
Website
https://www.basilea.com
Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries.

Basilea Pharmaceutica Headlines

No Headlines